📣 Introducing Tracenable Pro: Unlock Unlimited Data Exports & Disclosures Access.

Sichuan Kelun-Biotech Biopharmaceutical Co Ltd

Common Name
Sichuan Kelun-Biotech Biopharmaceutical
Country
China (Mainland)
Sector
Healthcare
Industry
Biotechnology
Employees
1,870
Ticker
6990
Exchange
HONG KONG EXCHANGES AND CLEARING LTD
Description
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. is a leading biopharmaceutical company engaged in the research, development, and manufacturing of innovative pharmaceutical products. The company focu...

Sichuan Kelun-Biotech Biopharmaceutical's GHG Emissions Data Preview

In 2023, Sichuan Kelun-Biotech Biopharmaceutical completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Sichuan Kelun-Biotech Biopharmaceutical has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2023202220212020 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Download Data
Access this data via API
$curl "https://tracenable.com/api/v1/ghg-emissions/absolute?ticker=6990&reporting_period=2024"

Verified Sources Behind Sichuan Kelun-Biotech Biopharmaceutical’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Sichuan Kelun-Biotech Biopharmaceutical’s data sources below and access millions more through our Disclosure Search.

a. Sichuan Kelun-Biotech Biopharmaceutical's Annual Report 2023
a. Sichuan Kelun-Biotech Biopharmaceutical's Annual Report 2023

Insights into Sichuan Kelun-Biotech Biopharmaceutical's Operational Emissions

In 2023, the total operational greenhouse gas (GHG) emissions ofSichuan Kelun-Biotech Biopharmaceutical amounted to19,903.34metric tons of CO2 equivalent.This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2).a

Sichuan Kelun-Biotech Biopharmaceutical's Scope 1 Emissions Over Time

202302 k4 k6 k8 ktCO2e
  • Total Scope 1
  • Year-over-Year Change

What are Sichuan Kelun-Biotech Biopharmaceutical's Scope 1 emissions?

In 2023, the total Scope 1 emissions of Sichuan Kelun-Biotech Biopharmaceutical were 6,335.07 metric tons of COâ‚‚ equivalent (tCOâ‚‚e).a

What are Sichuan Kelun-Biotech Biopharmaceutical's Scope 2 emissions?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 2 greenhouse gas (GHG) emissions of 13,568.27 tCOâ‚‚e without specifying the calculation method.a

What methodology does Sichuan Kelun-Biotech Biopharmaceutical use for Scope 2 reporting?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported its Scope 2 emissions using an unspecified methodology.a

Sichuan Kelun-Biotech Biopharmaceutical's Scope 2 Emissions Over Time

202303.5 k7 k10.5 k14 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Sichuan Kelun-Biotech Biopharmaceutical’s GHG Emissions Intensity Compared to Industry Peers

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported Scope 1 greenhouse gas (GHG) emissions of 6,335.07 tCOâ‚‚e and total revenues of USD 237 millions. This translates into an emissions intensity of 26.78 tCOâ‚‚e per millions USD.a

Sichuan Kelun-Biotech Biopharmaceutical's Scope 1 Emissions Intensity Compared to Peers

0.5102005,000100,000Scope 1 Emissions (tCO2e)2202001,00010,000Revenues (Millions of USD)AADSInnoCare PharmaYear: 2023Scope 1: 20 tCO2eRevenue: $M 104Scope 1 Intensity: 0.19 tCO2e/$MAntengeneYear: 2023Scope 1: 45 tCO2eRevenue: $M 10Scope 1 Intensity: 4.37 tCO2e/$MShanghai Henlius BiotechYear: 2023Scope 1: 6,909 tCO2eRevenue: $M 830Scope 1 Intensity: 8.32 tCO2e/$MRemeGenYear: 2024Scope 1: 54 tCO2eRevenue: $M 234Scope 1 Intensity: 0.23 tCO2e/$MGenscript BiotechYear: 2024Scope 1: 39,377 tCO2eRevenue: $M 4,637Scope 1 Intensity: 8.49 tCO2e/$MAAAscentage PharmaYear: 2023Scope 1: 2,081 tCO2eRevenue: $M 34Scope 1 Intensity: 61.05 tCO2e/$MShanghai Junshi BiosciencesYear: 2024Scope 1: 5,308 tCO2eRevenue: $M 267Scope 1 Intensity: 19.88 tCO2e/$MEverest MedicinesYear: 2024Scope 1: 1 tCO2eRevenue: $M 106Scope 1 Intensity: 0.00 tCO2e/$MInnovent BiologicsYear: 2024Scope 1: 48 tCO2eRevenue: $M 1,409Scope 1 Intensity: 0.03 tCO2e/$MAkesoYear: 2024Scope 1: 6,408 tCO2eRevenue: $M 318Scope 1 Intensity: 20.17 tCO2e/$MAAAurisco PharmaceuticalYear: 2024Scope 1: 2,731 tCO2eRevenue: $M 202Scope 1 Intensity: 13.51 tCO2e/$MCARsgen Therapeutics HoldingsYear: 2021Scope 1: 117 tCO2eRevenue: $M 4Scope 1 Intensity: 28.91 tCO2e/$MZai LabYear: 2023Scope 1: 15 tCO2eRevenue: $M 267Scope 1 Intensity: 0.06 tCO2e/$MDDDaShenLin Pharmaceutical GroupYear: 2024Scope 1: 5,220 tCO2eRevenue: $M 3,631Scope 1 Intensity: 1.44 tCO2e/$MZhifeiYear: 2024Scope 1: 13,576 tCO2eRevenue: $M 3,572Scope 1 Intensity: 3.80 tCO2e/$MKintor PharmaceuticalYear: 2021Scope 1: 29 tCO2eRevenue: $M 5Scope 1 Intensity: 5.35 tCO2e/$MAscletis PharmaYear: 2023Scope 1: 422 tCO2eRevenue: $M 9Scope 1 Intensity: 48.50 tCO2e/$M3SBioYear: 2024Scope 1: 13,304 tCO2eRevenue: $M 1,364Scope 1 Intensity: 9.75 tCO2e/$MVIVA Biotech HoldingsYear: 2022Scope 1: 1,404 tCO2eRevenue: $M 373Scope 1 Intensity: 3.76 tCO2e/$MPharmaron BeijingYear: 2024Scope 1: 34,268 tCO2eRevenue: $M 1,682Scope 1 Intensity: 20.37 tCO2e/$MJacobio Pharmaceuticals GroupYear: 2023Scope 1: 34 tCO2eRevenue: $M 10Scope 1 Intensity: 3.48 tCO2e/$MAsymchem Laboratories (Tianjin)Year: 2024Scope 1: 31,787 tCO2eRevenue: $M 795Scope 1 Intensity: 39.96 tCO2e/$MWuXi Biologics (Cayman)Year: 2024Scope 1: 38,346 tCO2eRevenue: $M 2,779Scope 1 Intensity: 13.80 tCO2e/$MAlphamab OncologyYear: 2023Scope 1: 3,970 tCO2eRevenue: $M 34Scope 1 Intensity: 117.90 tCO2e/$MSSSichuan Kelun-Biotech BiopharmaceuticalYear: 2023Scope 1: 6,335 tCO2eRevenue: $M 237Scope 1 Intensity: 26.78 tCO2e/$M

How does Sichuan Kelun-Biotech Biopharmaceutical's GHG emissions intensity compare to its peers?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical reported a Scope 1 emissions intensity of 26.78 tCOâ‚‚e per millions USD. Compared to the peer group median of 8.41, this places the company above its industry benchmark, indicating it is less carbon-efficient than most competitors.a

Where does Sichuan Kelun-Biotech Biopharmaceutical rank on GHG emissions intensity within its industry?

In 2023, Sichuan Kelun-Biotech Biopharmaceutical ranked 20 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCOâ‚‚e per millions USD).a

This places Sichuan Kelun-Biotech Biopharmaceutical among the least efficient performers, with one of the highest emissions intensities in its sector.a

Want Full Access to Sichuan Kelun-Biotech Biopharmaceutical's GHG Emissions Dataset?
Sign Up